Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity.
Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, Santos RD, Arsenault B, Cuevas A, Hu FB, Griffin BA, Zambon A, Barter P, Fruchart JC, Eckel RH, Matsuzawa Y, Després JP. Ross R, et al. Among authors: yamashita s. Nat Rev Endocrinol. 2020 Mar;16(3):177-189. doi: 10.1038/s41574-019-0310-7. Epub 2020 Feb 4. Nat Rev Endocrinol. 2020. PMID: 32020062 Free PMC article. Review.
Retarded intracellular lipid transport associated with reduced expression of Cdc42, a member of Rho-GTPases, in human aged skin fibroblasts: a possible function of Cdc42 in mediating intracellular lipid transport.
Tsukamoto K, Hirano K, Yamashita S, Sakai N, Ikegami C, Zhang Z, Matsuura F, Hiraoka H, Matsuyama A, Ishigami M, Matsuzawa Y. Tsukamoto K, et al. Among authors: yamashita s. Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1899-904. doi: 10.1161/01.atv.0000036080.42391.33. Arterioscler Thromb Vasc Biol. 2002. PMID: 12426222
Matrix metalloproteinases as novel disease markers in Takayasu arteritis.
Matsuyama A, Sakai N, Ishigami M, Hiraoka H, Kashine S, Hirata A, Nakamura T, Yamashita S, Matsuzawa Y. Matsuyama A, et al. Among authors: yamashita s. Circulation. 2003 Sep 23;108(12):1469-73. doi: 10.1161/01.CIR.0000090689.69973.B1. Epub 2003 Sep 2. Circulation. 2003. PMID: 12952836 Clinical Trial.
Where are we with probucol: a new life for an old drug?
Yamashita S, Matsuzawa Y. Yamashita S, et al. Atherosclerosis. 2009 Nov;207(1):16-23. doi: 10.1016/j.atherosclerosis.2009.04.002. Epub 2009 Apr 11. Atherosclerosis. 2009. PMID: 19457483 Review.
Did we abandon probucol too soon?
Yamashita S, Masuda D, Matsuzawa Y. Yamashita S, et al. Curr Opin Lipidol. 2015 Aug;26(4):304-16. doi: 10.1097/MOL.0000000000000199. Curr Opin Lipidol. 2015. PMID: 26125504 Review.
Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease.
Yamashita S, Masuda D, Ohama T, Arai H, Bujo H, Kagimura T, Kita T, Matsuzaki M, Saito Y, Fukushima M, Matsuzawa Y; PROSPECTIVE Study Group. Yamashita S, et al. J Atheroscler Thromb. 2016 Jun 1;23(6):746-56. doi: 10.5551/jat.32813. Epub 2016 Jan 22. J Atheroscler Thromb. 2016. PMID: 26803913 Free PMC article. Clinical Trial.
4,363 results